Insulin pump - Long-term effects on glycemic control: An observational study at 10 diabetes clinics in Sweden

Diabetes Technology and Therapeutics

Volumn 15, Issue 4, 2013, Pages 302-307

  Carlsson, Britt Marie ^a,b   Attvall, Stig ^b,c   Clements, Mark ^d   Gumpeny, Sridhar R ^e   Pivodic, Aldina ^f   Sternemalm, Lennart ^c   Lind, Marcus ^b,g  

^a Diabetes Section of Medicine   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e Endocrine and Diabetes Centre   (India)

^f Statistiska Konsultgruppen   (Sweden)

^g Department of Oral and Maxillofacial Surgery Otolaryngology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SWEDEN; THERAPY EFFECT;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; SWEDEN; TIME; TREATMENT OUTCOME;

EID: 84876155168     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0286     Document Type: Article

References (23)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
2. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
3. Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A: Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: An observational study. Lancet 2011;378:140-146.
4. Pickup JC, Renard E: Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 2008;31(Suppl 2):S140- S145.
5. Hanaire H, Lassmann-Vague V, Jeandidier N, Renard E, Tubiana-Rufi N, Vambergue A, Raccah D, Pinqet M, Guerci B: Treatment of diabetes mellitus using an external insulin pump: The state of the art. Diabetes Metab 2008;34:401-423.
6. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010;(1):CD005103.
7. Monami M, Lamanna C, Marchionni N, Mannuci E: Continuous subcutaneous insulin infusion (CSII) versus multiple daily insulin injections in type 1 diabetes mellitus: A metaanalysis. Acta Diabetol 2010;47:77-81.
8. Fahlén M, Eliasson B, Odén A: Optimization of basal insulin delivery in type 1 diabetes: A retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine. Diabet Med 2005; 22:382-386.
9. Carlsson B-M, Nord Andersson P, Almervik J, Carstensen J, Lind M: Availability of insulin pump therapy in clinical practice. Diabet Med 2012; 29:1055-1059.
10. www.journalia.se (accessed September 1, 2012).
11. Lind M, Fahlén M, Happich M, Odén A, Eliasson B: The effect of insulin lispro on glycaemic control in a large patient cohort. Diabetes Technol Ther 2009;11:51-56.
12. Lind M, Ode'n A, Fahle'n M, Eliasson B: The true value of HbA1c as a predictor of diabetic complications: Simulations of HbA1c variables. PLoS One 2009;4:e4412.
13. Lind M, Fahlén M, Eliasson B, Odén A: The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes. Primary Care Diabetes 2012:6:53-59.
14. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer HM; IFCC Working Group on HbA1c Standardization: IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study. Clin Chem 2004;50:166-174.
15. Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N: Clinical effectiveness and costeffectiveness of continuous subcutaneous insulin infusion for diabetes: Systematic review and economic evaluation. Health Technol Assess 2010;14(11):1-208.
16. Bruttomesso, D, Pianta A, Crazzolara, D, Scaldaferri E, Lora L, Guarneri G, Mongillo A, Gennaro R, Miola M, Moretti M, Confortin L, Beltramello GP, Pais M, Baritussio A, Casiglia E, Tiengo A: Continuous subcutaneous insulin infusion (CSII) in the Veneto region: Efficacy, acceptability and quality of life. Diabet Med 2002;19:628-634.
17. Olsovský J, Beránek M: The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI) [in Czech]. Vnitr Lek 2007;53:637-645.
18. Garmo A, Garmo H, Ärnlöv J, Leksell J: Long-term treatment effects of insulin pump therapy. Pract Diabetes Int 2011;28:295-299.
19. Lind M, Odén A, Fahlén M, Eliasson B: The shape of the metabolic memory of HbA1c: Re-analyzing the DCCT with respect to time-dependent effects. Diabetologia 2010;53: 1093-1098.
20. Pickup JC, Sutton AJ: Severe hypoglycaemia and glycaemic control in Type 1 diabetes: Meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-774.
21. Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, Bruttomesso D, Di Bartolo P, Girelli A, Leonetti F, Morviducci L, Ponzi P, Vitacolonna E: Quality of life and treatment satisfaction in adults with Type 1 diabetes: A comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med 2008;25:213-220.
22. Lind M: Glycaemic Control: Evaluation of HbA1c as a Risk Factor and the Effect of Modern Insulins in Clinical Practice. http://hdl.handle.net/2077/19641 (accessed September 1, 2012).
23. Workgroup on Hypoglycemia, American Diabetes Association: Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-1249.